购物车
0
有库存
HIT212712928
 sdf 文件
结构编辑
类似物检索
HIT212712928
  • HIT ID:HIT212712928
  • Cas No:669076-03-3
  • 常用名:JNJ-26076713
  • 别名:JNJ26076713
  • IUPAC:(3S)-4-{1-[3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propanoyl]piperidin-4-yl}-3-[(3S)-1,2,3,4-tetrahydroquinolin-3-yl]butanoic acid
    IUPAC:(3S)-4-{1-[3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propanoyl]piperidin-4-yl}-3-[(3S)-1,2,3,4-tetrahydroquinolin-3-yl]butanoic acid
  • InChI key:AJVBWPQQXWRZHQ-BJKOFHAPSA-N
  • 分子式:C29H38N4O3
  • 分子量:490.648
  • 氢键供体数 (HBD):3
  • 氢键受体数 (HBA):6
  • LogP:0.64970696
  • SMILES:OC(=O)C[C@H](CC1CCN(CC1)C(=O)CCC1=CC=C2CCCN=C2N1)[C@H]1CNc2ccccc2C1 |c:24,t:17,19|
    SMILES:OC(=O)C[C@H](CC1CCN(CC1)C(=O)CCC1=CC=C2CCCN=C2N1)[C@H]1CNc2ccccc2C1 |c:24,t:17,19|
  • JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    8-10周
    纯度
    -
    ¥ 37,400.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~